Combined Glucose Ingestion and Mouth Rinsing Improves Sprint Cycling Performance

2014 ◽  
Vol 24 (6) ◽  
pp. 605-612 ◽  
Author(s):  
Edwin Chong ◽  
Kym J. Guelfi ◽  
Paul A. Fournier
Keyword(s):  
Blood Glucose ◽  
Power Output ◽  
Cycling Performance ◽  
Cycle Ergometer ◽  
Peak Power Output ◽  
Mean Power ◽  
Glucose Ingestion ◽  
Sprint Cycling ◽  
Double Blinded ◽  
Mouth Rinsing

This study investigated whether combined ingestion and mouth rinsing with a carbohydrate solution could improve maximal sprint cycling performance. Twelve competitive male cyclists ingested 100 ml of one of the following solutions 20 min before exercise in a randomized double-blinded counterbalanced order (a) 10% glucose solution, (b) 0.05% aspartame solution, (c) 9.0% maltodextrin solution, or (d) water as a control. Fifteen min after ingestion, repeated mouth rinsing was carried out with 11 × 15 ml bolus doses of the same solution at 30-s intervals. Each participant then performed a 45-s maximal sprint effort on a cycle ergometer. Peak power output was significantly higher in response to the glucose trial (1188 ± 166 W) compared with the water (1036 ± 177 W), aspartame (1088 ± 128 W) and maltodextrin (1024 ± 202W) trials by 14.7 ± 10.6, 9.2 ± 4.6 and 16.0 ± 6.0% respectively (p < .05). Mean power output during the sprint was significantly higher in the glucose trial compared with maltodextrin (p < .05) and also tended to be higher than the water trial (p = .075). Glucose and maltodextrin resulted in a similar increase in blood glucose, and the responses of blood lactate and pH to sprinting did not differ significantly between treatments (p > .05). These findings suggest that combining the ingestion of glucose with glucose mouth rinsing improves maximal sprint performance. This ergogenic effect is unlikely to be related to changes in blood glucose, sweetness, or energy sensing mechanisms in the gastrointestinal tract.

scholarly journals The Ingestion of 39 or 64 g·hr−1 of Carbohydrate is Equally Effective at Improving Endurance Exercise Performance in Cyclists

2015 ◽  
Vol 25 (3) ◽  
pp. 285-292 ◽  
Author(s):  
Michael L. Newell ◽  
Angus M. Hunter ◽  
Claire Lawrence ◽  
Kevin D. Tipton ◽  
Stuart D. R. Galloway
Keyword(s):  
Power Output ◽  
Statistical Significance ◽  
Time Trial ◽  
Cycling Performance ◽  
Constant Load ◽  
Peak Power Output ◽  
Task Completion ◽  
Intake Rate ◽  
Mean Power ◽  
Pacing Strategy

In an investigator-blind, randomized cross-over design, male cyclists (mean± SD) age 34.0 (± 10.2) years, body mass 74.6 (±7.9) kg, stature 178.3 (±8.0) cm, peak power output (PPO) 393 (±36) W, and VO2max 62 (±9) ml·kg−1min−1 training for more than 6 hr/wk for more than 3y (n = 20) completed four experimental trials. Each trial consisted of a 2-hr constant load ride at 95% of lactate threshold (185 ± 25W) then a work-matched time trial task (~30min at 70% of PPO). Three commercially available carbohydrate (CHO) beverages, plus a control (water), were administered during the 2-hr ride providing 0, 20, 39, or 64g·hr−1 of CHO at a fluid intake rate of 1L·hr−1. Performance was assessed by time to complete the time trial task, mean power output sustained, and pacing strategy used. Mean task completion time (min:sec ± SD) for 39g·hr−1 (34:19.5 ± 03:07.1, p = .006) and 64g·hr−1 (34:11.3 ± 03:08.5 p = .004) of CHO were significantly faster than control (37:01.9 ± 05:35.0). The mean percentage improvement from control was −6.1% (95% CI: −11.3 to −1.0) and −6.5% (95% CI: −11.7 to −1.4) in the 39 and 64g·hr−1 trials respectively. The 20g·hr−1 (35:17.6 ± 04:16.3) treatment did not reach statistical significance compared with control (p = .126) despite a mean improvement of −3.7% (95% CI −8.8−1.5%). No further differences between CHO trials were reported. No interaction between CHO dose and pacing strategy occurred. 39 and 64g·hr−1 of CHO were similarly effective at improving endurance cycling performance compared with a 0g·hr−1 control in our trained cyclists.

scholarly journals Acute ibuprofen ingestion does not attenuate fatigue during maximal intermittent knee extensor or all-out cycling exercise

2019 ◽  
Vol 44 (2) ◽  
pp. 208-215 ◽  
Author(s):  
Paul T. Morgan ◽  
Anni Vanhatalo ◽  
Joanna L. Bowtell ◽  
Andrew M. Jones ◽  
Stephen J. Bailey
Keyword(s):  
Exercise Performance ◽  
Power Output ◽  
Knee Extensor ◽  
Cycling Performance ◽  
Similar Rate ◽  
Cycle Ergometer ◽  
Knee Extensors ◽  
Mean Power ◽  
Healthy Humans ◽  
The Mean

Recent research suggests that acute consumption of pharmacological analgesics can improve exercise performance, but the ergogenic potential of ibuprofen (IBP) administration is poorly understood. This study tested the hypothesis that IBP administration would enhance maximal exercise performance. In one study, 13 physically active males completed 60 × 3-s maximal voluntary contractions (MVCs) of the knee extensors interspersed with 2-s passive recovery periods, on 2 occasions, with the critical torque (CT) estimated as the mean torque over the last 12 contractions (part A). In another study, 16 active males completed two 3-min all-out tests against a fixed resistance on an electronically braked cycle ergometer, with the critical power estimated from the mean power output over the final 30 s of the test (part B). All tests were completed 60 min after ingestion of maltodextrin (placebo, PL) or 400 mg of IBP. Peripheral nerve stimulation was administered at regular intervals and electromyography was measured throughout. For part A, mean torque (IBP: 60% ± 13% of pre-exercise MVC; PL: 58% ± 14% of pre-exercise MVC) and CT (IBP: 41% ± 16% of pre-exercise MVC; PL: 40% ± 15% of pre-exercise MVC) were not different between conditions (P > 0.05). For part B, end-test power output (IBP: 292 ± 28 W; PL: 288 ± 31 W) and work done (IBP: 65.9 ± 5.9 kJ; PL: 65.4 ± 6.4 kJ) during the 3-min all-out cycling tests were not different between conditions (all P > 0.05). For both studies, neuromuscular fatigue declined at a similar rate in both conditions (P > 0.05). In conclusion, acute ingestion of 400 mg of IBP does not improve single-leg or maximal cycling performance in healthy humans.

scholarly journals Reliability of a laboratory-based long sprint cycling test: applications of the smallest worthwhile changes in performance for repeated measures designs

2018 ◽  
Vol 20 (2) ◽  
pp. 201-210
Author(s):  
Rogério Santos de Oliveira Cruz ◽  
Rafael Alves de Aguiar ◽  
Tiago Turnes ◽  
Felipe Domingos Lisbôa ◽  
João Antônio Gesser Raimundo ◽  
...  
Keyword(s):  
Power Output ◽  
Repeated Measures ◽  
Intraclass Correlation ◽  
Cycling Performance ◽  
Systematic Change ◽  
Confidence Limits ◽  
Mean Power ◽  
Sprint Cycling ◽  
Repeated Measures Designs ◽  
Mean Power Output

The aims of the present study were to assess the reliability of long sprint cycling performance in a group of recreationally trained cyclists and to provide thresholds for changes in performance for this particular group of subjects in repeated measures designs through a scale of magnitudes. Repeatability of mean power output during a 1-min cycling time trial was assessed in a group of 15 recreationally trained cyclists (26 ± 5, years, 176 ± 5 cm, 78 ± 8 kg). They were tested on separate days, approximately one week apart. The test and retest values for the whole group of cyclists were 7.0 ± 0.5 W/kg and 6.9 ± 0.6 W/kg (systematic change and 90% confidence limits of -1.0% ± 1.1%). Our results indicated good test-retest reproducibility (typical error of 1.8%, 90% confidence limits of 1.4% to 2.6%; intraclass correlation coefficient of 0.96, confidence limits of 0.91 to 0.99), but suggested a reduction of mean power for the “slower” subjects on retest (-2.0%, 90% confidence limits of ±1.8%). If not monitored, this systematic decrease could interfere in results of studies utilizing groups with similar performance levels, particularly investigating strategies to improve performance in sprint cycling exercises around 1 min. The thresholds for moderate, large, very large and extremely large effects for mean power output on long sprint cycling performance are about 0.4%, 1.3%, 2.3%, 3.6%, and 5.8%, respectively.

scholarly journals Isovelocity vs. Isoinertial Sprint Cycling Tests for Power- and Torque-cadence Relationships

2019 ◽  
Vol 40 (14) ◽  
pp. 897-902 ◽  
Author(s):  
Mehdi Kordi ◽  
Jonathan Folland ◽  
Stuart Goodall ◽  
Paul Barratt ◽  
Glyn Howatson
Keyword(s):  
Performance Measures ◽  
Power Output ◽  
Peak Power ◽  
Cycling Performance ◽  
Peak Power Output ◽  
Maximum Torque ◽  
Functional Measures ◽  
Sprint Cycling ◽  
Optimal Cadence

AbstractSprint cycling performance is heavily dependent on mechanical peak power output (PPO) and the underlying power- and torque-cadence relationships. Other key indices of these relationships include maximum torque (TMAX), cadence (CMAX) and optimal cadence (COPT). Two common methods are used in the laboratory to ascertain PPO: isovelocity and isoinertial. Little research has been carried out to compare the magnitude and reliability of these performance measures with these two common sprint cycling assessments. The aim of this study was to compare the magnitude and reliability of PPO, TMAX, CMAX and COPT measured with isovelocity and isoinertial sprint cycling methods. Two experimental sessions required 20 trained cyclists to perform isoinertial sprints and then isovelocity sprints. For each method, power-cadence and torque-cadence relationships were established, and PPO and COPT were interpolated and TMAX and CMAX were extrapolated. The isoinertial method produced significantly higher PPO (p<0.001) and TMAX (p<0.001) than the isovelocity method. However, the isovelocity method produced significantly higher COPT (p<0.001) and CMAX (p=0.002). Both sprint cycling tests showed high levels of between-session reliability (isoinertial 2.9–4.4%; isovelocity 2.7–4.0%). Functional measures of isovelocity and isoinertial sprint cycling tests were highly reliable but should not be used interchangably.

The Effects of 4 Different Recovery Strategies on Repeat Sprint-Cycling Performance

2013 ◽  
Vol 8 (5) ◽  
pp. 542-548 ◽  
Author(s):  
Christos K. Argus ◽  
Matthew W. Driller ◽  
Tammie R. Ebert ◽  
David T. Martin ◽  
Shona L. Halson
Keyword(s):  
Power Output ◽  
Passive Control ◽  
Lactate Concentration ◽  
Blood Lactate Concentration ◽  
Cycling Performance ◽  
Mean Power ◽  
Compression Garments ◽  
Recovery Strategies ◽  
Sprint Cycling ◽  
Mean Power Output

Purpose:To evaluate the effectiveness of different recovery strategies on repeat cycling performance where a short duration between exercise bouts is required.Methods:Eleven highly trained cyclists (mean ± SD; age = 31 ± 6 y, mass = 74.6 ± 10.6 kg, height = 180.5 ± 8.1 cm) completed 4 trials each consisting of three 30-s maximal sprints (S1, S2, S3) on a cycle ergometer, separated by 20-min recovery periods. In a counterbalanced, crossover design, each trial involved subjects performing 1 of 4 recovery strategies: compression garments (COMP), electronic muscle stimulation (EMS), humidification therapy (HUM), and a passive control (CON). The sprint tests implemented a 60-s preload (at an intensity of 4.5 W/kg) before a 30-s maximal sprint. Mean power outputs (W) for the 3 sprints, in combination with perceived recovery and blood lactate concentration, were used to examine the effect of each recovery strategy.Results:In CON, S2 and S3 were (mean ± SD) –2.1% ± 3.9% and –3.1% ± 4.2% lower than S1, respectively. Compared with CON, COMP resulted in a higher mean power output from S1 to S2 (mean ± 90%CL: 0.8% ± 1.2%; possibly beneficial) and from S1 to S3 (1.2% ± 1.9%; possibly beneficial), while HUM showed a higher mean power output from S1 to S3 (2.2% ± 2.5%; likely beneficial) relative to CON.Conclusion:The authors suggest that both COMP and HUM may be effective strategies to enhance recovery between repeated sprint-cycling bouts separated by ~30 min.

scholarly journals Growth hormone responses to repeated maximal cycle ergometer exercise at different pedaling rates

2002 ◽  
Vol 92 (2) ◽  
pp. 602-608 ◽  
Author(s):  
K. A. Stokes ◽  
M. E. Nevill ◽  
G. M. Hall ◽  
H. K. A. Lakomy
Keyword(s):  
Growth Hormone ◽  
Area Under The Curve ◽  
Cycle Ergometer ◽  
Mean Power ◽  
Ergometer Exercise ◽  
Hormone Responses ◽  
Sprint Cycling ◽  
Mean Power Output ◽  
Male Subjects ◽  
Serum Gh

The present study examined the growth hormone (GH) response to repeated bouts of maximal sprint cycling and the effect of cycling at different pedaling rates on postexercise serum GH concentrations. Ten male subjects completed two 30-s sprints, separated by 1 h of passive recovery on two occasions, against an applied resistance equal to 7.5% (fast trial) and 10% (slow trial) of their body mass, respectively. Blood samples were obtained at rest, between the two sprints, and for 1 h after the second sprint. Peak and mean pedal revolutions were greater in the fast than the slow trial, but there were no differences in peak or mean power output. Blood lactate and blood pH responses did not differ between trials or sprints. The first sprint in each trial elicited a serum GH response (fast: 40.8 ± 8.2 mU/l, slow: 20.8 ± 6.1 mU/l), and serum GH was still elevated 60 min after the first sprint. The second sprint in each trial did not elicit a serum GH response ( sprint 1 vs. sprint 2, P < 0.05). There was a trend for serum GH concentrations to be greater in the fast trial (mean GH area under the curve after sprint 1vs. after sprint 2: 1,697 ± 367 vs. 933 ± 306 min · mU−1 · l−1; P = 0.05). Repeated sprint cycling results in an attenuation of the GH response.

scholarly journals Anaerobic energy provision does not limit Wingate exercise performance in endurance-trained cyclists

2003 ◽  
Vol 94 (2) ◽  
pp. 668-676 ◽  
Author(s):  
J. A. L. Calbet ◽  
J. A. De Paz ◽  
N. Garatachea ◽  
S. Cabeza de Vaca ◽  
J. Chavarren
Keyword(s):  
Exercise Performance ◽  
Power Output ◽  
Acute Hypoxia ◽  
Lactate Concentration ◽  
Oxygen Deficit ◽  
Peak Power Output ◽  
Fatigue Index ◽  
Mean Power ◽  
Anaerobic Energy ◽  
Mean Power Output

The aim of this study was to evaluate the effects of severe acute hypoxia on exercise performance and metabolism during 30-s Wingate tests. Five endurance- (E) and five sprint- (S) trained track cyclists from the Spanish National Team performed 30-s Wingate tests in normoxia and hypoxia (inspired O2 fraction = 0.10). Oxygen deficit was estimated from submaximal cycling economy tests by use of a nonlinear model. E cyclists showed higher maximal O2 uptake than S (72 ± 1 and 62 ± 2 ml · kg−1 · min−1, P < 0.05). S cyclists achieved higher peak and mean power output, and 33% larger oxygen deficit than E ( P< 0.05). During the Wingate test in normoxia, S relied more on anaerobic energy sources than E ( P < 0.05); however, S showed a larger fatigue index in both conditions ( P < 0.05). Compared with normoxia, hypoxia lowered O2 uptake by 16% in E and S ( P < 0.05). Peak power output, fatigue index, and exercise femoral vein blood lactate concentration were not altered by hypoxia in any group. Endurance cyclists, unlike S, maintained their mean power output in hypoxia by increasing their anaerobic energy production, as shown by 7% greater oxygen deficit and 11% higher postexercise lactate concentration. In conclusion, performance during 30-s Wingate tests in severe acute hypoxia is maintained or barely reduced owing to the enhancement of the anaerobic energy release. The effect of severe acute hypoxia on supramaximal exercise performance depends on training background.

Topical Sodium Bicarbonate: No Improvement in Blood Buffering Capacity or Exercise Performance

2020 ◽  
Vol 15 (7) ◽  
pp. 1005-1011
Author(s):  
Alannah K.A. McKay ◽  
Peter Peeling ◽  
Martyn J. Binnie ◽  
Paul S.R. Goods ◽  
Marc Sim ◽  
...  
Keyword(s):  
Body Weight ◽  
Sodium Bicarbonate ◽  
Peak Power ◽  
Cycling Performance ◽  
Blood Parameters ◽  
Buffering Capacity ◽  
Capillary Blood ◽  
Peak Power Output ◽  
Mean Power ◽  
Experimental Trials

Purpose: To assess the efficacy of a topical sodium bicarbonate (0.3 g/kg body weight NaHCO3) application (PR lotion; Amp Human) on blood buffering capacity and performance in recreationally active participants (study A) and moderately trained athletes (study B). Methods: In Study A, 10 participants completed 2 experimental trials: oral NaHCO3 (0.3 g/kg body weight + placebo lotion) or PR lotion (0.9036 g/kg body weight + oral placebo) applied 90 minutes prior to a cycling task to exhaustion (30-s sprints at 120% peak power output with 30-s rest). Capillary blood was collected and analyzed for pH, bicarbonate, and lactate every 10 minutes throughout the 90-minute loading period and postexercise at 5, 10, and 15 minutes. In Study B, 10 cyclists/triathletes completed 2 experimental trials, applying either PR or placebo lotion 30 minutes prior to a cycling performance task (3 × 30-s maximal sprints with 90-s recovery). Capillary blood samples were collected at baseline, preexercise, and postexercise and analyzed as per study A. Results: In Study A, pH and bicarbonate were significantly elevated from baseline after 10 minutes in the oral NaHCO3 condition and throughout recovery compared with no elevation in the PR lotion condition (P < .001). No differences in cycling time occurred between PR lotion (349 [119] s) and oral NaHCO3 (363 [80] s; P = .697). In Study B, no differences in blood parameters, mean power (P = .108), or peak power (P = .448) were observed between conditions. Conclusions: PR lotion was ineffective in altering blood buffering capacity or enhancing performance in either trained or untrained individuals.

Mouth Rinsing and Ingesting a Bitter Solution Improves Sprint Cycling Performance

2014 ◽  
Vol 46 (8) ◽  
pp. 1648-1657 ◽  
Author(s):  
SHARON GAM ◽  
KYM J. GUELFI ◽  
PAUL A. FOURNIER
Keyword(s):  
Cycling Performance ◽  
Sprint Cycling ◽  
Mouth Rinsing

scholarly journals No Influence of Nonivamide-nicoboxil on the Peak Power Output in Competitive Sportsmen

2021 ◽  
Author(s):  
Theresa Schörkmaier ◽  
Yvonne Wahl ◽  
Christian Brinkmann ◽  
Wilhelm Bloch ◽  
Patrick Wahl
Keyword(s):  
Power Output ◽  
Peak Power ◽  
Near Infrared ◽  
Endurance Performance ◽  
Cycle Ergometer ◽  
Muscle Oxygenation ◽  
Peak Power Output ◽  
Exercise Tests ◽  
Hypoxic Conditions ◽  
Placebo Cream

AbstractRecent studies have shown that the oxygenated hemoglobin level can be enhanced during rest through the application of nonivamide-nicoboxil cream. However, the effect of nonivamide-nicoboxil cream on oxygenation and endurance performance under hypoxic conditions is unknown. Therefore, the purpose of this study was to investigate the effects of nonivamide-nicoboxil cream on local muscle oxygenation and endurance performance under normoxic and hypoxic conditions. In a cross-over design, 13 athletes (experienced cyclists or triathletes [age: 25.2±3.5 years; VO2max 62.1±7.3 mL·min−1·kg−1]) performed four incremental exercise tests on the cycle ergometer under normoxic or hypoxic conditions, either with nonivamide-nicoboxil or placebo cream. Muscle oxygenation was recorded with near-infrared spectroscopy. Capillary blood samples were taken after each step, and spirometric data were recorded continuously. The application of nonivamide-nicoboxil cream increased muscle oxygenation at rest and during different submaximal workloads as well as during physical exhaustion, irrespective of normoxic or hypoxic conditions. Overall, there were no significant effects of nonivamide-nicoboxil on peak power output, maximal oxygen uptake or lactate concentrations. Muscle oxygenation is significantly higher with the application of nonivamide-nicoboxil cream. However, its application does not increase endurance performance.

Sign in / Sign up

Export Citation Format

Share Document